Diabetes, Vol 49, Issue 9 1492-1499, Copyright © 2000 by American Diabetes Association

ARTICLES

Transgenic mice with increased hexosamine flux specifically targeted to beta-cells exhibit hyperinsulinemia and peripheral insulin resistance

J Tang, JL Neidigh, RC Cooksey and DA McClain
Department of Internal Medicine, University of Utah, Salt Lake City 84132, USA.

Hexosamines have been shown to mediate effects of hyperglycemia and so-called "glucose toxicity" in insulin-sensitive tissues. To determine the effects of hexosamines on insulin synthesis and secretion, transgenic mice were created to overexpress the rate-limiting enzyme for hexosamine synthesis, glutamine:fructose-6-phosphate amidotransferase (GFA), specifically in beta-cells. GFA activity in islets of heterozygous transgenic mice was elevated 76% compared with littermate controls. The increased GFA activity led to 1.4- and 2.1-fold increased pancreatic insulin content in 2- and 10-month-old transgenic mice, respectively (P < 0.005). Fasting insulin levels were 1.6-fold higher than in littermate controls (P < 0.05). Hyperinsulinemia was evident despite a 28% reduction in insulin mRNA levels. The fasting glucose levels in the transgenic mice equaled that of controls aged 2-4 months but exceeded that of the controls aged 6-10 months (means +/- SE 6.9 +/- 0.2 vs. 5.9 +/- 0.2 mmol/l, P < 0.001). By 8 months, the males were overweight and mildly diabetic (fasting glucose 8.8 +/- 0.5 mmol/l) despite persistent hyperinsulinemia. Insulin resistance was confirmed in both males and females using the euglycemic-hyperinsulinemic clamp technique; glucose disposal rates decreased by 48% in transgenic mice (P < 0.01). Triglyceride levels did not differ, and free fatty acid levels were lower in the transgenic animals. ATP levels were unchanged in the transgenic islets. We conclude that hexosamine biosynthesis is involved in the regulation of insulin content in beta-cells by glucose. Increased hexosamine flux in the beta-cell results in hyperinsulinemia, insulin resistance, and (in males) mild type 2 diabetes.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				N. L. Vanderford, S. S. Andrali, and S. Ozcan Glucose Induces MafA Expression in Pancreatic Beta Cell Lines via the Hexosamine Biosynthetic Pathway J. Biol. Chem., January 19, 2007; 282(3): 1577 - 1584. [Abstract] [Full Text] [PDF]

				R. C. Cooksey, S. Pusuluri, M. Hazel, and D. A. McClain Hexosamines regulate sensitivity of glucose-stimulated insulin secretion in {beta}-cells Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E334 - E340. [Abstract] [Full Text] [PDF]

				D. C. Love and J. A. Hanover The Hexosamine Signaling Pathway: Deciphering the "O-GlcNAc Code" Sci. Signal., November 29, 2005; 2005(312): re13 - re13. [Abstract] [Full Text] [PDF]

				D. A. McClain, M. Hazel, G. Parker, and R. C. Cooksey Adipocytes with increased hexosamine flux exhibit insulin resistance, increased glucose uptake, and increased synthesis and storage of lipid Am J Physiol Endocrinol Metab, May 1, 2005; 288(5): E973 - E979. [Abstract] [Full Text] [PDF]

				R. C. Cooksey, H. A. Jouihan, R. S. Ajioka, M. W. Hazel, D. L. Jones, J. P. Kushner, and D. A. McClain Oxidative Stress, {beta}-Cell Apoptosis, and Decreased Insulin Secretory Capacity in Mouse Models of Hemochromatosis Endocrinology, November 1, 2004; 145(11): 5305 - 5312. [Abstract] [Full Text] [PDF]

				C. Bouche, S. Serdy, C. R. Kahn, and A. B. Goldfine The Cellular Fate of Glucose and Its Relevance in Type 2 Diabetes Endocr. Rev., October 1, 2004; 25(5): 807 - 830. [Abstract] [Full Text] [PDF]

				J. J. Collier and D. K. Scott Sweet Changes: Glucose Homeostasis Can Be Altered by Manipulating Genes Controlling Hepatic Glucose Metabolism Mol. Endocrinol., May 1, 2004; 18(5): 1051 - 1063. [Abstract] [Full Text] [PDF]

				M. Hazel, R. C. Cooksey, D. Jones, G. Parker, J. L. Neidigh, B. Witherbee, E. A. Gulve, and D. A. McClain Activation of the Hexosamine Signaling Pathway in Adipose Tissue Results in Decreased Serum Adiponectin and Skeletal Muscle Insulin Resistance Endocrinology, May 1, 2004; 145(5): 2118 - 2128. [Abstract] [Full Text] [PDF]

				H. Zhang, Y. Jia, J. J. Cooper, T. Hale, Z. Zhang, and S. C. Elbein Common Variants in Glutamine:Fructose-6-Phosphate Amidotransferase 2 (GFPT2) Gene Are Associated with Type 2 Diabetes, Diabetic Nephropathy, and Increased GFPT2 mRNA Levels J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 748 - 755. [Abstract] [Full Text] [PDF]

				G. J. Parker, K. C. Lund, R. P. Taylor, and D. A. McClain Insulin Resistance of Glycogen Synthase Mediated by O-Linked N-Acetylglucosamine J. Biol. Chem., March 14, 2003; 278(12): 10022 - 10027. [Abstract] [Full Text] [PDF]

				D. C. Love, J. Kochran, R. L. Cathey, S.-H. Shin, and J. A. Hanover Mitochondrial and nucleocytoplasmic targeting of O-linked GlcNAc transferase J. Cell Sci., February 15, 2003; 116(4): 647 - 654. [Abstract] [Full Text] [PDF]

				J. L. Evans, I. D. Goldfine, B. A. Maddux, and G. M. Grodsky Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes Endocr. Rev., October 1, 2002; 23(5): 599 - 622. [Abstract] [Full Text] [PDF]

				D. A. McClain, W. A. Lubas, R. C. Cooksey, M. Hazel, G. J. Parker, D. C. Love, and J. A. Hanover Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia PNAS, August 6, 2002; 99(16): 10695 - 10699. [Abstract] [Full Text] [PDF]

				K. O. Broschat, C. Gorka, J. D. Page, C. L. Martin-Berger, M. S. Davies, H.-c. Huang, E. A. Gulve, W. J. Salsgiver, and T. P. Kasten Kinetic Characterization of Human Glutamine-fructose-6-phosphate Amidotransferase I. POTENT FEEDBACK INHIBITION BY GLUCOSAMINE 6-PHOSPHATE J. Biol. Chem., April 19, 2002; 277(17): 14764 - 14770. [Abstract] [Full Text] [PDF]

				G. F. Lewis, A. Carpentier, K. Adeli, and A. Giacca Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes Endocr. Rev., April 1, 2002; 23(2): 201 - 229. [Abstract] [Full Text] [PDF]

				R. G. Spiro Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds Glycobiology, April 1, 2002; 12(4): 43R - 56R. [Abstract] [Full Text] [PDF]

				V. Emilsson, J. O'Dowd, A. L. Nolan, and M. A. Cawthorne Hexosamines and Nutrient Excess Induce Leptin Production and Leptin Receptor Activation in Pancreatic Islets and Clonal {beta}-Cells Endocrinology, October 1, 2001; 142(10): 4414 - 4419. [Abstract] [Full Text] [PDF]

				H. Kaneto, G. Xu, K.-H. Song, K. Suzuma, S. Bonner-Weir, A. Sharma, and G. C. Weir Activation of the Hexosamine Pathway Leads to Deterioration of Pancreatic beta -Cell Function through the Induction of Oxidative Stress J. Biol. Chem., August 10, 2001; 276(33): 31099 - 31104. [Abstract] [Full Text] [PDF]